Pharma companies need to rethink how they communicate and share information and insights within their own organisations, according to Syneos Health’s principal for real world and late phase
When pharmaceutical and biotech companies are working on their brand strategy and conducting brand planning it is vital that they understand what makes their healthcare customers tick.
The need for pharmaceutical companies to meet or, ideally exceed, the expectations their customers have of them is not new to the industry. Yet new research indicates that many in
Pharmaceutical companies provide one of the, if not the, most important products to HCPs - the medical advances that make a huge difference to patient outcomes. But bringing new me
The UK pharmaceutical industry is just getting to grips with working under two new approaches to regulating branded medicines spend; the 2019 Voluntary Scheme for Branded Medicines Pricing
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.